Back to Agenda
Session 2b. RA Parallel Session : OPTIMIZING REGULATORY ECOSYSTEM through Innovation, Collaboration & Convergence
Session Chair(s)
Sandy Chan
Associate Director, Regulatory Policy & Intelligence Lead- Asia Pacific, Johnson & Johnson, Singapore
Helene Sou, MSC, RAC
Global Regulatory Policy and Innovation, Takeda Pharmaceutical Company Limited., Singapore
Speaker(s)
Helene Sou, MSC, RAC
Global Regulatory Policy and Innovation, Takeda Pharmaceutical Company Limited., Singapore
Stephanie Chen
Associate Director, Regulatory Policy APAC, MERCK AND CO INC, Singapore
Susanne Ausborn, PHD
Global Head International Regulatory Policy, Roche, Switzerland
Noraisyah binti Mohd Sani
Head, New Drug Product Section, NPRA, Ministry of Health Malaysia, Malaysia
Yee Hoo Looi, PHD
Deputy Director, Therapeutic Products Branch, HSA, Singapore
PREEYAPHON PUTTIJUGLUKSA
New Drug and Investigational Drug, Medicines Regulation Division, Thai FDA , Thailand
Hyang Won Min, MSC, RPH
Vice President, Head of APAC Regulatory Affairs, Johnson & Johnson, Singapore
Wipada Rodtanaporn
Head of Regulatory Sciences, Pfizer (thailand) Co., Ltd., Thailand
Somprasong Preuttanuparp
Head of Regulatory Affairs - Thailand and Frontier Markets, AstraZeneca (Thailand) Ltd., Thailand
Stephanie, Hui Min Ong
Head of Regulatory, SANOFI-AVENTIS SINGAPORE PTE. LTD., Malaysia
Anna Litsiou, PHD, MBA, MSC
Regulatory Policy & Intelligence Director, AstraZeneca, United Kingdom
Elaine Blair, PHD
Senior Director, Regulatory Affairs APAC, PTC Therapeutics, Australia
Have an account?